Article

Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?

American Journal of Psychiatry (Impact Factor: 13.56). 06/2008; 165(5):553-5. DOI: 10.1176/appi.ajp.2008.08020237
Source: PubMed
0 Followers
 · 
90 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Le trouble déficit de l’attention-hyperactivité (TDAH) peut être une comorbidité psychiatrique chez les usagers de substance. Cet article a pour but d’étudier le lien entre le TDAH et les addictions. Pour cela, nous décrirons le tableau clinique du TDAH chez l’adulte et la prévalence des addictions dans cette population. Nous aborderons ensuite les modèles explicatifs qui pourraient permettre de mieux comprendre la forte intrication du TDAH et des pratiques addictives. Enfin, nous évoquerons l’influence à long terme du traitement psychostimulant chez les enfants hyperactifs et les recommandations actuelles de prise en charge des usagers de substances souffrant d’un TDAH. Attention deficit hyperactivity disorder (ADHD) is a common psychiatric comorbidity in substance use disorders. The aim of this article is to review the link between ADHD and addictive disorders. For this purpose, we will describe the clinical symptomatology of ADHD in adults and the prevalence of addiction in this population. We will broach the explanatory models for this comorbidity. Finally, we will evoke the long-term consequences of psychostimulant treatment in children with ADHD and the current treatment recommendations for substance users suffering from ADHD.
    PSN 11/2009; 7(3):116-121. DOI:10.1007/s11836-009-0090-6 · 0.07 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite the increased risk of substance use disorders (SUDs) on individuals with attention-deficit/hyperactivity disorder (ADHD), the mechanism of risk remains unclear. Given the high prevalence of ADHD in patients receiving treatment for addiction, all patients in treatment for SUDs should be screened for ADHD. Clinicians should develop skills in the use of appropriate instruments, including rating scales, as well as the assessment for developmentally appropriate manifestations and impairments associated with adolescent and adult forms of ADHD. Medication should never be provided in isolation from psychosocial treatment directed at the patient’s SUD.
    Current Attention Disorders Reports 03/2009; 1(1):12-18. DOI:10.1007/s12618-009-0003-6
  • Source